Philippe Slos
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Biotechnology top 5%
Papers in
- Oncology 13
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 3
- Immunology 10
- Immunotherapy and Immune Responses 8
- Co-authors
- Annick MercenierBruce AcresPatrick SquibanStéphane PaulMargaret LiuJean‐Marc BalloulNadine BizouarneYves Lemoine
- Journals
- Cancer Gene Therapy (3 papers)Cancer Research (3 papers)Applied and Environmental Microbiology (2 papers)Journal of Clinical Oncology (2 papers)Biochimie (2 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Philippe Slos
25 papers receiving 762 citations
Peers
Comparison fields: 5 of 66
- Immunology 287
- Biotechnology 95
- Genetics 254
- Food Science 159
- Oncology 211
Countries citing papers authored by Philippe Slos
This map shows the geographic impact of Philippe Slos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Slos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Slos more than expected).
Fields of papers citing papers by Philippe Slos
This network shows the impact of papers produced by Philippe Slos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Slos. The network helps show where Philippe Slos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philippe Slos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 0 | |
| 2 | 2017 | 19 | |
| 3 | 2017 | 2 | |
| 4 | 2013 | 59 | |
| 5 | 2008 | 39 | |
| 6 | 2004 | 137 | |
| 7 | 2004 | 82 | |
| 8 | 2003 | 18 | |
| 9 | 2003 | 16 | |
| 10 | 2003 | 49 | |
| 11 | 2001 | 40 | |
| 12 | 1998 | 13 | |
| 13 | 1998 | 33 | |
| 14 | 1997 | 40 | |
| 15 | 1994 | 25 | |
| 16 | 1992 | 19 | |
| 17 | 1988 | 41 | |
| 18 | 1988 | 14 | |
| 19 | 1988 | 19 | |
| 20 | 1987 | 46 |
About Philippe Slos
Philippe Slos is a scholar working on Oncology, Immunology, Biotechnology, Food Science and Genetics, having authored 26 papers that have together received 805 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (8 papers), Probiotics and Fermented Foods (8 papers), Immunotherapy and Immune Responses (8 papers), Bacterial Genetics and Biotechnology (4 papers), Bacteriophages and microbial interactions (3 papers), Cancer Research and Treatments (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Immunology (287 citations), Biotechnology (95 citations), Genetics (254 citations), Food Science (159 citations) and Oncology (211 citations). Philippe Slos has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Annick Mercenier, Bruce Acres, Patrick Squiban, Stéphane Paul, Margaret Liu, Jean‐Marc Balloul, Nadine Bizouarne, Yves Lemoine, Dennis Romero and Catherine Robert. Their work appears in journals such as Cancer Gene Therapy, Cancer Research, Applied and Environmental Microbiology, Journal of Clinical Oncology and Biochimie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.